Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Gross Profit (2021 - 2025)

HeartSciences' Gross Profit history spans 5 years, with the latest figure at $1411.0 for Q4 2025.

  • For Q4 2025, Gross Profit changed N/A year-over-year to $1411.0; the TTM value through Jan 2026 reached $5021.0, down 59.89%, while the annual FY2025 figure was $2470.0, 80.27% down from the prior year.
  • Gross Profit reached $1411.0 in Q4 2025 per HSCS's latest filing, up from $1140.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $10139.0 in Q1 2024 to a low of $1140.0 in Q3 2025.
  • Average Gross Profit over 5 years is $2637.7, with a median of $1807.0 recorded in 2021.
  • Peak YoY movement for Gross Profit: tumbled 36.9% in 2023, then skyrocketed 752.02% in 2024.
  • A 5-year view of Gross Profit shows it stood at $1728.0 in 2021, then tumbled by 32.64% to $1164.0 in 2022, then soared by 104.47% to $2380.0 in 2023, then soared by 326.01% to $10139.0 in 2024, then crashed by 86.08% to $1411.0 in 2025.
  • Per Business Quant, the three most recent readings for HSCS's Gross Profit are $1411.0 (Q4 2025), $1140.0 (Q3 2025), and $2470.0 (Q2 2025).